New hope for kids with kidney disease: fewer relapses with ripertamab?
NCT ID NCT07388810
First seen Feb 05, 2026 · Last updated May 23, 2026 · Updated 17 times
Summary
This study tests whether one or two doses of ripertamab can help children aged 16 and older with nephrotic syndrome who relapse often or depend on steroids. The goal is to see which dose keeps them relapse-free longer and reduces steroid use. About 312 children will take part, and the results will show if this treatment can better control the disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FRNS/SDNS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Children's Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang Province 310052
Hangzhou, Zhejiang, China
Conditions
Explore the condition pages connected to this study.